Literature DB >> 7746406

EEG reactivity in the prognosis of severe head injury.

E Gütling1, A Gonser, H G Imhof, T Landis.   

Abstract

We compared reactivity of EEG to external stimuli--an easily and quickly available measure--with the central conduction time (CCT) of the somatosensory evoked potentials, currently the most-used electrophysiologic method to predict outcome in severe head injury (SHI), and with the initial Glasgow Coma Scale (GCS) score. In 50 patients, comatose subsequent to SHI, we measured EEG reactivity and CCT within 48 to 72 hours and compared them with the outcome after 1.5 years. Using discriminant analysis, EEG reactivity correctly classified 92%, CCT classified 82%, and both measures together classified 98% of the patients into globally good or bad outcome groups. GCS allowed a correct classification in only 72% and, combined with either of the two electrophysiologic measures, did not further increase predictability. EEG reactivity is an excellent long-term global outcome predictor in SHI, superior to CCT and GCS. When the two electrophysiologic measures are combined, a prognostic accuracy is achieved that is better than that of any other reported method.

Entities:  

Mesh:

Year:  1995        PMID: 7746406     DOI: 10.1212/wnl.45.5.915

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Continuous EEG monitoring in the intensive care unit.

Authors:  Jeffrey D Kennedy; Elizabeth E Gerard
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 2.  Are somatosensory evoked potentials the best predictor of outcome after severe brain injury? A systematic review.

Authors:  B G Carter; W Butt
Journal:  Intensive Care Med       Date:  2005-04-22       Impact factor: 17.440

3.  Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage.

Authors:  Jan Claassen; Lawrence J Hirsch; Jennifer A Frontera; Andres Fernandez; Michael Schmidt; Gregory Kapinos; John Wittman; E Sander Connolly; Ronald G Emerson; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Continuous Electroencephalography After Moderate to Severe Traumatic Brain Injury.

Authors:  Hyunjo Lee; Moshe A Mizrahi; Jed A Hartings; Sameer Sharma; Laura Pahren; Laura B Ngwenya; Brian D Moseley; Michael Privitera; Frank C Tortella; Brandon Foreman
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

Review 5.  Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM.

Authors:  Jan Claassen; Fabio S Taccone; Peter Horn; Martin Holtkamp; Nino Stocchetti; Mauro Oddo
Journal:  Intensive Care Med       Date:  2013-05-08       Impact factor: 17.440

6.  The Reemergence of EEG Reactivity After Cardiac Arrest.

Authors:  Joseph Zachariah; Alejandro A Rabinstein
Journal:  Neurohospitalist       Date:  2016-12-18

Review 7.  Electroencephalogram in the intensive care unit: a focused look at acute brain injury.

Authors:  Ayham Alkhachroum; Brian Appavu; Benjamin Rohaut; Jan Claassen; Satoshi Egawa; Brandon Foreman; Nicolas Gaspard; Emily J Gilmore; Lawrence J Hirsch; Pedro Kurtz; Virginie Lambrecq; Julie Kromm; Paul Vespa; Sahar F Zafar
Journal:  Intensive Care Med       Date:  2022-08-23       Impact factor: 41.787

8.  Acute brain failure in severe sepsis: a prospective study in the medical intensive care unit utilizing continuous EEG monitoring.

Authors:  Emily J Gilmore; Nicolas Gaspard; Huimahn A Choi; Emily Cohen; Kristin M Burkart; David H Chong; Jan Claassen; Lawrence J Hirsch
Journal:  Intensive Care Med       Date:  2015-03-13       Impact factor: 17.440

Review 9.  Critical care management of severe traumatic brain injury in adults.

Authors:  Samir H Haddad; Yaseen M Arabi
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-02-03       Impact factor: 2.953

Review 10.  Electrophysiologic monitoring in acute brain injury.

Authors:  Jan Claassen; Paul Vespa
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.